Checkpoint inhibition for treating Hodgkin and Non-Hodgkin lymphoma in allo HSCT
Pneumocystis Pneumonia (PcP) after allo HSCT
This study aims to investigate safety and efficacy of immune checkpoint inhibitor treatment before and after allogeneic stem cell transplantation in NHL and HL.
For more information about the Lymphoma Working Party and about this study, please click HERE
To fill in the survey please click HERE
This study aims to identify pre- and post-transplant factors associated with development of PcP after allogeneic HSCT.
For more information about the Infectious Diseases Working Party and about this study, please click HERE